E
Elitza S Theel
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
Aug 28, 2026
Diagnostic Access and Equity
2:31
2:56
3:18
3:30

Elitza TheelGUEST
And we've designed it to focus on studies that look at a number of things, um, including things like pathogens that disproportionately affect underserved populations, point of care innovations that are designed for low resource or more remote settings, and then practical approaches for how to implement and deliver this sort of diagnostic testing where laboratory infrastructure is a bit more limited.

Elitza TheelGUEST
Um, we also are welcoming research and studies that evaluate the health and economic impact of these strategies, recognizing that improving access means, again, not only developing new tests, but also dem- demonstrating that their value, or what their value is in a real world healthcare setting.

Elitza TheelGUEST
Um, and I'd say generally kind of the launch of this section really ref- reflects our growing recognition that even the most accurate diagnostic test has limited impact if it's avail...

Elitza TheelGUEST
I- if it isn't available, affordable, and effectively implemented where it's, um, where it's needed most.
6 MINS LATER
